Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages > 6 Months to < 6 Years With Allergic Rhinitis.
Latest Information Update: 02 Jul 2015
At a glance
- Drugs Azelastine (Primary)
 - Indications Allergic rhinitis
 - Focus Adverse reactions
 - Sponsors Meda
 
Most Recent Events
- 11 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
 - 25 Jun 2013 New trial record